top
Refine your search
Refine your search
My Search
dual antiplatelet therapy
Slides
Poster session
Clear all filters
Date
Since yesterday
This week
This month
This year
Last year
Two years ago
Older than three years
Related Terms
Percutaneous coronary intervention (5)
Clinical outcomes (3)
Stent implantation (3)
Antiplatelet regimens (2)
Coronary stenting (2)
Platelet reactivity (2)
Stented patients (2)
Systematic review (2)
Insulin resistance (1)
MIRROR study (1)
Parathyroid hormone levels (1)
Prospective multicenter registry (1)
Vitamin D levels (1)
Acetylsalicylic acid (1)
Acute coronary syndromes (1)
Altered fibrin (1)
Antiplatelet activity (1)
Antiplatelet effect (1)
Antiplatelet therapy cessation (1)
Antiplatelet therapy non-adherence (1)
Aortic valve implantation (1)
Bleeding events (1)
Chronic dual antiplatelet (1)
Clinical decision (1)
Coronary artery disease (1)
Drug-eluting balloons (1)
E-HEALING registry (1)
Fatty acids (1)
Genetic polymorphism (1)
National health insurance (1)
Oral dual antiplatelet (1)
Outcome difference (1)
Oxidative stress (1)
Peripheral arterial interventions (1)
Pharmacodynamic profiles (1)
Randomized controlled trials (1)
Registry substudy (1)
Renal impairment (1)
Thrombin formation (1)
Thrombotic events (1)
Transcatheter aortic valve (1)
more
less
Search terms
Results 1 - 10 of 28 - ordered by :
Date
Relevance
Date
Pages:
1
2
3
P2Y12 receptor specific versus non-P2Y12 receptor specific platelet function testing for prediction of pharmacodynamic and clinical outcomes in patients on dual antiplatelet therapy
Poster session 6
Twelve versus 30 month dual antiplatelet therapy after percutaneous coronary intervention using national health insurance review & assessment (HIRA) database
Poster session 4
Parathyroid hormone levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with acetylsalicylic acid and clopidogrel or ticagrelor
Poster session 4
Impact of renal impairment on platelet reactivity and clinical outcomes during chronic dual antiplatelet therapy following coronary stenting
Poster session 2
Is there gender-related outcome difference with oral dual antiplatelet therapy in patients with acute coronary syndromes? A systematic review and meta-analysis.
Poster session 2
Incidence and predictors of long-term dual antiplatelet therapy over 3 years after drug-eluting stent implantation
Poster session 2
Pre-procedural dual antiplatelet therapy and bleeding events following transcatheter aortic valve implantation (TAVI)
Poster session 5
Triple versus dual antiplatelet therapy in patients undergoing unprotected left main percutaneous coronary intervention
Poster session 3
Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: a comparison between the DAPT trial and 9 other trials evaluating DAPT duration.
Poster session 2
Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor
Poster session 2
SEE MORE
